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ABSTRACT 
 
The 72 kDa heat shock protein (HSP72) is a molecular chaperone that binds native protein with low affinity. These interactions can 
alter function of the substrate, a property known as HSP-mediated activity control. In the present work, BIAcore instrumentation was 
used to monitor binding reactions between HSP72 and naturally occurring sequence variants of the measles virus (MV) nucleocapsid 
protein (N), a structural protein regulating transcription/replication of the viral genome. Binding reactions employed synthetic peptides 
mimicking a putative HSP72 binding motif of N. Sequences were identified that bound HSP72 with affinities comparable to well-
characterized activity control reactions. These sequences, but not those binding with lesser affinity, supported HSP72 activity control of 
MV transcription/replication. BIAcore instrumentation thus provides an effective way to measure biologically relevant low affinity 
interactions with structural variants of viral proteins. 
 
 
INTRODUCTION 
 
The 70kDa family of heat shock proteins contains important 
intracellular molecular chaperones. The molecules may either be 
constitutively expressed or induced under conditions of cellular 
stress such as fever or viral infection. HSP72 is the major 
inducible member of the 70kDa family and can bind both 
denatured and native protein substrates. Typically, the HSP72 
binding motif can be defined by a linear sequence of 7 amino 
acids containing hydrophobic side groups or aromatic rings (1). 
Incorrectly folded and/or denatured proteins have increased 
exposure of highly hydrophobic sequences on their surface. 
Association between HSP72 and these malfolded proteins can 
delay or prevent their self-aggregation and thereby promote 
proper folding, a function known as HSP72-mediated protein 
stability control. The other function of HSP72 in substrate 
binding is known as activity control. In this capacity, HSP72 
interacts with native proteins through domains containing 
clusters of hydrophobic amino acid side groups on the surface 
(2). The interaction can help to stabilize or alter conformation 
and thus function of the substrate, particularly if the binding 
target resides within an intrinsically disordered domain (3). For 
both types of interactions, association and dissociation of 
substrate molecules is regulated by ATP-ADP exchange in the 
nucleotide binding site of HSP. This property is illustrated by 
activity control binding reactions involving E.coli DnaK, the 
prokaryotic analogue of HSP72, and the transcription factor δ32 
(2). In the presence of ATP, the HSP72 substrate-binding pocket 
is open and substrate association/dissociation is rapid. In the 
presence of ADP, the pocket is closed and substrate dissociation 
is slow, decreasing the KD for the binding reaction. Cycles of 
ADP-ATP exchange are thus the basis for the highly reversible 
nature of HSP-substrate interactions. Overall, affinity between 
HSP and substrate is greater in stability control reactions 
compared to activity control reactions. Typical affinities between 
HSP72 and unfolded protein substrate are in the nM range. In 
contrast, DnaK binding affinity for native proteins is typically in 
the µM range, with reaction KD’s reported between 0.01–1µM (4, 
5) and 1-50 µM (6).  
 
Studies have demonstrated HSP72’s interaction with viral 
structural proteins in a manner that promotes viral gene Zhang and Oglesbee     
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expression (7-9). Previous work from our laboratory documented 
a role for HSP72 in the measles virus (MV) and canine distemper 
virus (CDV) life cycle. MV and CDV are negative-strand RNA 
viruses within the morbillivirus genus of Paramyxoviridae. These 
viruses have a helical ribonucleoprotein (RNP) core particle 
consisting of the single-stranded RNA genome packaged by the 
nucleocapsid protein (N). This RNP serves as template for the 
virus-encoded RNA-dependent RNA polymerase. HSP72 
reversibly associates with the CDV and MV RNP in an ATP-
dependent manner, resulting in increased RNP transcriptional 
activity (10-13). The phenomenon is consistent with HSP72–
mediated activity control since the HSP72 substrate is pre-
formed and binding results in altered function of the substrate. 
Several lines of evidence support N protein as the target for 
HSP72 binding. First, confocal immunofluorescence microscopy 
of infected cells show co-localization of HSP72 and N protein 
but not other viral core proteins (14). Secondly, the stoichiometry 
of RNP-HSP72 interaction indicates a target of high copy 
number that exceeds all but that of the N protein. Finally, N 
protein is the determinant of RNP structure and HSP72-RNP 
binding alters RNP morphology (12). The N protein domain 
mediating HSP72 binding should be located on the carboxyl 
terminus since only the carboxyl terminus of N is exposed when 
incorporated into the RNP (26). An HSP72 binding motif was 
identified within this region represented by the sequence Y N D 
R N L L (15). This sequence has typical elements that predict 
binding for all 70kDa heat shock protein family members, 
including HSP72, HSP73, and BiP (HSP78) (1). The algorithm 
developed for BiP shows a preference for substrates containing 
aromatic (Y) and hydrophobic (L) amino acids while basic amino 
acids (R) are tolerated. In fact, inclusion of basic residues confers 
selectivity for HSP72 binding (16). Acidic residues (D) may be 
present, although they diminish binding affinity, while non-
charged residues (N) have neither positive nor negative impact 
upon binding (16). The region of the MV N protein 
encompassing this binding motif is intrinsically disordered (17), 
providing a mechanistic basis by which HSP72-N protein binding 
events could alter N protein conformation and thus function as 
template for viral RNA synthesis. 
 
The objective of the present study was to employ surface 
plasmon resonance technology in the identification of MV N 
protein carboxyl terminal sequences that engage in low affinity 
interactions with HSP72, correlating results of binding studies to 
those that measure functional interactions. Conventional 
methods of measuring binding interactions were considered 
poorly suited to the analysis of low-affinity HSP72-substrate 
affinity control reactions, where the affinity of HSP72 for various 
substrates is compared. Use of chromatographic co-purification 
or co-immunoprecipitation has not been reported in such an 
application, possibly because of the limited sensitivity of these 
methods. Solid phase binding of HSP72 to cellulose-bound 
peptide was used to screen the binding targets of DnaK (18). 
Peptide co-crystallization was also used to identify the motifs 
recognized by DnaK (19). Use of a yeast two hybrid system 
would appear amenable to such an application, although this has 
not been described. These latter methods are labor intensive 
and/or better suited to describing presence or absence of specific 
binding rather than characterization of binding reaction constants 
that distinguish amongst closely-related substrates. Use of surface 
plasmon resonance technology that is the basis for Biomolecular 
Interaction Analysis (BIAcore) instrumentation  represents the 
most expedient approach by which low-affinity protein 
interactions can be measured in real-time. With BIAcore, one 
interaction partner is conjugated on the surface of a sensor chip 
(ligand) and the other binding partner flows over the surface 
(analyte), facilitating the analysis of binding differences between 
multiple analytes and a single ligand. The approach is based on an 
optical detection system that monitors real-time changes in 
protein mass on the sensor surface. Binding events result in 
changes in protein mass that, in turn, alter surface plasmon 
resonance, an electro-magnetic phenomenon that dampens the 
intensity of light reflected off of the surface of the sensor chip at 
a specific angle (i.e., resonance angle). The change of resonance 
angle resulting from analyte-ligand interaction is measured in 
resonance units (RU) and plotted in sensorgrams as a function of 
time. A response of 1000 RU corresponds to a change of about 1 
ng/mm2 in surface protein concentration. Affinity values of 
analyte-ligand binding are then derived through fitting the 
resultant sensorgrams to those in a bank of well-characterized 
binding reactions. A high quality fit between unknown and 
standard reactions is the basis for identifying reaction constants 
that include on rate (ka), off rate (kd), and a calculated equilibrium 
dissociation constant (KD).  
 
Synthetic peptides containing carboxyl terminal sequences of the 
N protein were used as analyte in binding reactions with 
immobilized HSP72. Use of peptide instead of monomeric N 
protein (N0) reflects the difficulty in obtaining N0 in pure form 
(i.e., without P protein) and the fact that N0 contains extensive 
hydrophobic regions in the amino-terminal three fourths of the 
molecule that predict HSP72- N0 interaction but are likely 
irrelevant to RNP-HSP72 binding since these regions are 
inaccessible when N is incorporated into the RNP. Peptides 15 
amino acids in length were based upon the Edmonston MV 
sequence, the strain upon which vaccines are based. Variant 
peptides were also designed to incorporate one or two 
modifications in the HSP72 binding motif that reflect naturally 
occurring sequence polymorphisms, including N to D and/or L 
to P substitutions. Positive and negative controls for specific 
binding to HSP72 included a fifteen amino acid peptide 
representing the HSP72 binding motif of P53 (20) and a fifteen 
amino acid myelin basic protein-derived peptide (21), respectively. 
Relevance of peptide-HSP72 interaction analysis to RNP-HSP72 
binding was defined by examining the ability of free peptide to 
inhibit RNP-HSP72 interaction on BIAcore sensors. The 
contribution of the carboxyl terminus of MV N protein in 
mediating HSP72 binding was further documented using intact 
MV RNP and MV RNP with the carboxyl terminus removed in 
the binding reactions. Our results showed that the BIAcore 
approach readily identified naturally occurring sequence 
polymorphisms in the carboxyl terminus of MV N protein that 
exhibited reduced binding to HSP72, a result correlated to loss of 
activity control in functional assays. 
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MATERIALS AND METHODS 
 
Peptide analytes 
 
Synthetic peptides were 15 amino acids in length. Peptide N 
represented the extreme carboxyl terminus of the Edmonston 
MV N protein. Peptide N4D contained an asparagine (N) to 
aspartic acid (D) substitution at the fourth residue upstream from 
the carboxyl terminus. The sequence is characteristic of MV 
central nervous system isolates belonging to genotypes C1, C2, 
D1, E, and F (22). Peptide N3P4D contained an additional 
leucine (L) to proline (P) substitution and is also based upon a 
MV central nervous system isolate belonging to the C1 genotype. 
The P53 peptide represented a 15 amino acid sequence 
previously shown to mediate binding between P53 and HSP72 
(20). The myelin basic protein (MBP) peptide contained a 15 
amino acid sequence that was not predicted to bind HSP72 using 
the BiP algorithm. All peptides were custom synthesized 
(Genemed Synthesis Inc, San Francisco, CA) with the exception 
of MBP peptide. The latter was purchased from a commercial 
source (Sigma, St. Louis, MO). All peptides were purified to 
greater than 95% purity by high-pressure liquid chromatography 
and characterized by mass spectral analysis. Complete peptide 
sequences were as follows: 
 
N:          DTDTPIVYNDRNLLD 
N4D:    DTDTPIVYNDRDLLD 
N3PD:   DTDTPIVYNDRDPLD 
p53:        STSRHKKLMFKTEGP 
MBP: YGSLPQKAQRPQDEN 
 
Binding reactions were performed in HBS-P running buffer (0.01 
M HEPES pH 7.4, 0.15 M NaCl, 0.005% Surfactant P20) adjusted to a final 
concentration of 2.5 mM MgAcetate and 2.5 mM ATP 
(Disodium Salt, Sigma). Buffer was fully degassed and filtered 
before use. Lyophilized peptides were directly resuspended in 
running buffer to a concentration of 1 mM. Injection of peptides 
contained in running buffer minimized sensorgram bulk shifts 
caused by changes in buffer conditions on the sensor surface. 
Analyte concentration is used in rate constant calculations, 
making accurate analyte concentration measurements essential. In 
the present work, peptide mass before reconstitution was 
determined on a Mettler H54AR scale (Product of Metter-Toledo 
Inc., Columbus, OH) to an accuracy of 0.01 mg. To prevent 
analyte loss as a consequence of adsorption to the walls of 
microfuge tubes or pipette tips, all items used in the manipulation 
of samples were coated with Sigmacote (Sigma), a chlorinated 
organopolysiloxane reagent.  
 
Viral ribonucleoprotein analytes 
 
MV RNP was purified as previously described (13). Briefly, 
infected Vero cells were harvested at the time of maximum virus 
induced cytopathic effect. The ATP concentration of cell lysates 
was adjusted to a final concentration of 2.5 mM to assure 
dissociation of HSP72 from RNP particles so that subsequent 
analysis of binding reactions between RNP and HSP72 could be 
performed without interference from pre-formed HSP72-RNP 
complexes (23). Viral RNP was purified from clarified 
cytoplasmic extracts by CsCl isopycnic density centrifugation at 
27,000 xg for 2 hours at 4oC. RNP-containing gradient fractions 
were pooled and dialyzed against HBS-P buffer for use in binding 
analyses. RNP particles, when intact, are over 1 µm in length, 
although actual length is quite heterogeneous due to 
fragmentation that occurs during isolation (24). The combination 
of large and small particle sizes can induce aberrations (i.e., 
spikes) in the sensorgrams. Accordingly, RNP preparations were 
sheared by vigorously vortexing solutions for 1 min. Previous 
electron microscopic evaluation of RNP preparations showed 
that such manipulation reduces the range in particle length, 
resulting in a smaller mean, a smaller standard deviation of the 
mean, and a reduction in the amplitude of sensorgram spikes 
(Oglesbee et al., unpublished observation, 25). RNP total protein 
was characterized by 12% SDS-PAGE. The N protein 
concentration was established by comparing its Coomassie 
staining intensity to that of a standard curve created with 0.075, 
0.15, 0.3, 0.6, and 1.2 µg bovine serum albumin. The protein 
composition of nucleocapsid isolated in this manner is 88% N 
protein, 9% P protein, and 1% L protein by mass based upon 
relative Coomassie staining intensities.  
 
RNP containing N protein monomers lacking the carboxyl 
terminal 15 kDa was generated by digestion with Staphylococcus 
aureus V8 protease (Pierce, Rockford, IL). Such digestion 
preserves the amino terminal 45 kDa portion of the N protein 
monomer that is essential for RNP structural integrity (26). 
Enzyme was added to RNP total protein in HBS-P running 
buffer to a final concentration of 4.8 U/ml. Reactions were 
adjusted to an N protein concentration of 80 nM. Digests were 
performed at 37oC for 20 min. Cleavage of N protein was 
confirmed and the concentration determined by SDS-PAGE 
using the BSA standard as previously described. The protease was 
not separated from RNP in order to avoid excessive sample 
manipulation, an approach made feasible due to the negligible 
contribution of V8 protease to the total sample protein (i.e., < 
1%). The presence of V8 protease in the binding reactions did 
not affect HSP72 immobilization levels on the sensor surfaces 
nor was HSP72 binding activity affected, based upon subsequent 
analysis of characterized binding reactions between HSP72 and 
peptide analytes. Based upon these observations, V8 protease did 
not cause significant degradation of HSP72 ligand.   
 
Preparation of BIAcore sensor surfaces 
 
To prepare HSP72 for immobilization, an aqueous HSP72 
solution (1.1 mg/ml recombinant human HSP72)(Stressgen 
Biotechnologies, Victoria, BC Canada) was dialyzed against 
Acetate buffer 5.0 (10 mM sodium acetate pH 5.0) overnight using 
Slide-A-Lyzer cassettes with a 10 kDa cut–off (Pierce 
Biotechnology, Rockford, IL). A range of HSP72 loading levels Zhang and Oglesbee     
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were resolved by 12% SDS-PAGE and the signal intensities of 
Coomassie stained proteins quantitated by laser densitometry. 
The HSP72 concentration was determined through regression 
analysis of a standard curve generated with BSA as described 
above. The isoelectric point of HSP72 is 5.41 such that a net 
positive charge was imparted upon the protein in the pH 5.0 
acetate buffer. The positive charge, in turn, facilitated the 
electrostatic interaction between HSP72 and the carboxymethylated 
dextran matrix on the surface of the CM5 sensor chip. This pre-
concentration step was designed to maximize the final yield of covalently linked 
protein. Use of lower pH buffers were not used in order to avoid 
loss in biologic activity of the HSP72 ligand.  
 
Covalent linkage of HSP72 to the dextran matrix was achieved by 
amine coupling (Amine Coupling kit, BIAcore Inc.). Activation 
of the carboxyl groups on the matrix was performed by adding a 
mixture of succinimide (NHS, 11.5 mg/ml in deionized water) 
and carbodiimide (EDC, 75 mg/ml in deionized water) to form 
active esters that react spontaneously with amine groups on the 
HSP72 molecules. The degree of HSP72 immobilization was 
achieved through manual injection of 5 µg/ml HSP72 pulses 
followed by continuous flow of HBS-P buffer at 10 µl/min. 
Non-covalently bound HSP72 was generally eluted within 5 
minutes, with the difference in sensorgram baseline between pre- 
and post-HSP72 injection representing the HSP72 
immobilization level. After the desired level of immobilization 
was achieved, a 1 M ethanolamine solution was injected to 
deactivate remaining active esters. 
 
A total of 4 different binding surfaces or flow channels were 
prepared on each chip. Flow channel 1 (FC1) was activated with 
NHS/EDC and blocked with ethanolamine but no HSP72 was 
conjugated. The resultant FC1 was used as a negative control for 
non-specific interactions between analyte and sensor surfaces. 
Remaining flow channels contained different immobilization 
levels of HSP72. Twenty thousand RU of HSP72 (where 1,000 
RU equals to 1 ng/mm2 of HSP72 on the surface) was used to 
establish the presence and specificity of peptide binding. The 
high immobilization levels were designed to generate large 
sensorgram deviations following binding by the relatively small 
peptide analytes. Ten thousand RU of HSP72 was used for the 
kinetic analysis of peptide binding reactions and to establish the 
specificity of HSP72-nucleocapsid binding. Two hundred fifty 
RU of HSP72 was immobilized for kinetic analysis of HSP72-
nucleocapsid binding reactions. Sensorgrams readily returned to 
baseline in the dissociation phase of the HSP72-analyte binding 
reactions, obviating the need for a sensor surface regeneration 
step. 
 
Binding reaction analysis 
 
Signal changes on the activated/blocked control channel were 
subtracted from the peptide-HSP72 or RNP-HSP72 binding 
interactions using in-line reference and the subtracted 
sensorgrams were analyzed. Since HSP72 has only a single 
peptide binding cleft per molecule, curves generated with serial 
analyte concentrations were applied globally to the 1:1 Langmuir 
binding model with or without correction for baseline drifting 
depending on baseline status. Chi2 and residual values were used 
to evaluate the quality of fit between the experimental data and 
individual binding models. Plots of residuals indicate the 
difference between the experimental and reference data for each 
point in the fit. The Chi2 value represents the sum of squared 
differences between the experimental data and reference data at 
each point. 
 
RESULTS AND DISCUSSION 
 
Design rationale 
 
Peptides that mimic the carboxyl terminal 15 amino acids of the 
MV N protein were tested for their ability to bind HSP72. The 
BIAcore approach is based upon the ability to detect changes in 
mass on a sensor surface that, when corrected for non-specific 
interactions between the analyte in solution and unmodified 
sensor surfaces, reflect binding reactions with the immobilized 
ligand. Using the BIAcore optical detection system, binding of 
analyte having a large mass is more readily detected than binding 
of small analytes. Accordingly, optimal detection of binding 
events could be based upon use of HSP72 as analyte and peptide 
as ligand. The limitation of this approach is that it is not 
conducive to comparing binding reactions between HSP72 and 
multiple substrates. First, one would have to examine binding 
reactions between HSP72 and multiple levels of immobilized 
peptide to provide assurance that differences in calculated 
equilibrium dissociation constants reflected differences in peptide 
sequence and not differences in the level of immobilization 
between peptides. Secondly, use of purified recombinant HSP72 
as analyte would be cost prohibitive considering the 
concentration ranges required for analysis, the volume of analyte 
solutions required, and the challenges to recovery of HSP72 
without loss of binding activity following each run. Decline in 
HSP72 binding capacity with time was documented by 
comparing sensorgrams generated on a freshly prepared sensor 
and the same sensor following storage at 4ºC for 4 days (Fig. 1). 
Loss of binding activity was not attributable to regeneration 
conditions used between binding reactions (i.e., conditions 
promoting complete remove of analyte prior to subsequent 
binding reaction analysis). In our experiments, addition of ATP 
to the running buffer helped return sensorgram baseline to pre-
reaction values following peptide or RNP injections. Accordingly, 
there was no need to regenerate the surface using more harsh 
dissociation conditions (Fig. 2), and run-to-run variability in 
results recorded within a given experimental session was not 
significant. Peptide inhibition of RNP-HSP72 interaction is 
another way to indirectly monitor peptide-HSP72 interaction. 
This approach takes advantage of the large sensorgram shift 
when RNP segments bind the sensor, each segment composed of 
multiple 60 kDa N protein monomers. Use of RNP analytes is 
amenable to establishing the specificity of peptide-HSP72 
interactions and defining binding reaction constants (27), Zhang and Oglesbee     
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however, we chose direct peptide-HSP72 interaction analysis 
since large amounts of peptide analyte were much more readily 
obtained than were RNP preparations fragmented to a range of 
particle sizes amenable to BIAcore analysis, making the direct 
analysis a much more expedient approach.  
 
Sensor selection and binding reaction conditions 
 
Using peptide as analyte, we were able to detect binding events 
by using peptides 15 amino acids in length versus the nominal 
seven amino acids that comprise the putative HSP72 binding 
motif, by optimizing reaction buffer conditions, and by 
increasing the density of HSP72 immobilized on the sensor chip. 
Increased peptide size facilitates detection of binding and 
improves peptide solubility. In addition to 2.5 mM ATP, reaction 
buffers were supplemented with 2.5 mM magnesium acetate and 
surfactant P-20. The Mg++ was added to better mimic 
physiologic conditions supporting ATP/ADP-dependent 
HSP72-substrate interactions. Our results showed that inclusion 
of Mg++  increased specific binding over background. Peptide 
interaction with irrelevant ligand (i.e., IgG) was not influenced by 
Mg++  whereas peptide binding to HSP72 was significantly 
increased by the inclusion of Mg++ in the reaction buffer (Fig. 3). 
Surfactant P-20 was included in the buffer system to help reduce 
analyte aggregation. A broad range of ligand densities was made 
possible through use of the CM5 sensor chips. The surface of 
these chips has long dextran arms to which ligand can be 
covalently linked. The longer the arms, the greater the potential 
ligand density. Preliminary studies examined use of surfaces 
lacking a dextran matrix (i.e., C1 chip) and sensors with short 
dextran linker arms (i.e., F1 chip). Both of these conditions 
proved unsuitable for the analysis of HSP72-peptide binding. 
The C1 chip did not support levels of HSP72 immobilization that 
allowed detection of binding by the small peptide analytes. The 
F1 chip supported HSP70 immobilization levels comparable to 
that used on CM5 chips in subsequent kinetic analyses, however, 
the background reactivity between peptide and activated/blocked 
flow channels was unacceptably high. 
 
Peptide binding specificity 
 
High HSP72 immobilization densities were used to established 
specificity of binding between MV N peptide and HSP72 (data 
not shown; see reference 15). The binding pattern between 
HSP72 and 1 mM MV-N peptide was similar to that of HSP72 
and 1mM p53 peptide, a positive control based upon sequences 
known to mediate p53-HSP72 interaction (20). Both peptides 
caused a change in RU on the unmodified sensor surfaces that 
did not change with time, a phenomenon known as bulk shift. 
Bulk shift simply represents the change in refractive index over 
the sensor that is caused by changes in buffer composition. Bulk 
shift was contrasted to the progressive rise in signal observed 
over time as MV N and p53 peptides passed over the flow 
channel to which HSP72 was immobilized, indicating binding. 
The progressive nature of binding reflected the relative excess of 
ligand, where binding equilibrium was not achieved. Specificity 
was demonstrated with MBP as analyte, where identical 
sensorgrams were obtained with 1 mM peptide solution and flow 
channels containing no ligand or flow channels containing either 
HSP72 or irrelevant protein (i.e., IgG) as ligand. In addition, 
signal over bulk shift was not observed for MV N and p53 
peptides passed over flow channels to which irrelevant ligand 
(IgG) was immobilized. While amenable to establishing specificity 
of binding, these reaction conditions were not suitable for 
determining reaction rate and equilibrium constants. The high 
ligand immobilization creates a mass transfer effect, where 
reaction rates are limited by analyte availability and not on/off 
rates (see Reference 30 for review).  
 
To establish the relevance of MV N peptide-HSP72 interaction 
to MV RNP-HSP72 interaction, a binding competition assay was 
performed (Fig. 4). Either N peptide or MBP peptide was mixed 
with 1nM N protein in the form of fragmented MV RNP, and 
the mixture was injected over flow channels containing HSP72. 
N peptide inhibited MV RNP binding to HSP72 in a dosage-
dependent manner, with 5, 20, and 50 µM peptide decreasing 
RNP binding by 21, 50, and 63% respectively. Inhibition of RNP 
binding was based upon the magnitude of reduction of the 
maximal sensorgram response during RNP injection. Higher 
peptide concentrations were not employed since the optical 
system could directly detect peptide-HSP72 binding events in this 
concentration range. Sensorgrams of competitive inhibition using 
5 µM peptide was the most accurate reflection of RNP binding 
events since binding of peptide alone could not be detected. 
Relevance of MBP peptide-HSP72 interaction to MV RNP-
HSP72 interaction was not observed with 5-400 µM MBP, since 
400 µM MBP peptide inhibited RNP binding to HSP72 by only 
18%. The tremendous excess of peptide to N protein in these 
latter reactions suggests that the inhibition was non-specific.  
 
Kinetic measurements using N peptide 
 
To define the binding affinity between MV-N peptides and 
HSP72, we performed a kinetic analysis of the interaction using 
an HSP72 immobilization level of 10,000 RU (Fig. 5). This level 
was considered optimal based upon calculation of the maximal 
response of analyte to ligand (Rmax) where, for optimal kinetic 
analyses, the Rmax should fall within the range of 50 to 250 RU. 
The theoretical Rmax is based on the formula Rmax = 
(MWA/MWL) x RL  x  Sm  where MWA/MWL is the ratio of 
molecular weight of analyte to ligand, RL is the amount of ligand 
bound in RU, and Sm represents the proposed stoichiometry of 
the interaction. In this case, the MWA/MWL ratio is 1:40. HSP72 
has only a single peptide binding site such that the Sm equals 1 
(28). Thus, the Rmax of 250RU was achieved at 10,000 RU of 
HSP72. Lower levels of HSP72 immobilization (i.e., ligand RU) 
were not used because peptide concentrations similar to the KD 
produced poor signal under these conditions, thereby limiting the 
range of peptide concentrations that could be analyzed. To 
enhance the reliability of calculated reaction constants, 
sensorgrams from a range of analyte concentrations should be 
compared, where that range encompasses the predicted KD for 
the reaction, and the results of individual sensorgrams combined 
in a single global analysis. The KD  for HSP72 activity control Zhang and Oglesbee     
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binding reactions was estimated at 1-50 µM based upon 
published data from the analysis of binding reactions with DnaK, 
the bacterial analogue of HSP72 (6). At 10,000 RU HSP72, we 
could examine binding events at 25 µM peptide, a value 
approximating the predicted KD, whereas peptide binding at 
2,000 RU was only evident at concentrations equal to or in excess 
of 100 µM. The maximal peptide concentration that could be 
used for either HSP72 immobilization level was 200 µM. In 
excess of this value, sensorgrams from individual binding 
reactions deviated from the 1:1 Langmuir binding model, yielding 
unacceptably high residuals and Chi2 values, criteria used to judge 
the quality of fit between experimental data and that derived 
from binding models. Plots of residuals indicate the difference 
between the experimental and reference data for each point in 
the fit. In general, a good fit has small residuals in the -2 to +2 
range that randomly distribute around the x-axis. The Chi2 value 
represents the sum of squared differences between the 
experimental data and reference data at each data point. 
Typically, good fittings derive Chi2 values less than 10. Deviation 
from the 1:1 model at high analyte concentration is consistent 
with secondary interactions that may occur between peptide 
analytes or between peptide and ligand. Accordingly, 10,000 RU 
of HSP72 supported global analysis of 4 serial 2-fold 
concentrations of N peptide (25-200 µM), compared to only 2 
serial 2-fold peptide concentrations at 2,000 RU HSP72, and 
yielded a KD = 1 with residuals between ± 1.8 with a Chi2 value 
of 0.23 (Table 1). Using HSP72 immobilization levels of 20,000 
RU, we observed a similar lower limit to peptide detection, with 
sensorgrams from all peptide concentrations between 25 and 200 
µM yielding non-randomly distributed residuals that exceed the ± 
2 range and Chi2 values in excess of 10 (Fig. 5).  
 
Structural variation in the HSP72 binding motif 
 
Our approach to peptide-HSP72 interaction analysis allowed us 
t o  d e t e c t  d i f f e r e n c e s  i n  b i nding affinity for peptides 
incorporating one or two amino acid substitutions. For all 
reactions, individual sensorgrams that did not fit the 1:1 binding 
model were excluded from the global fit for kinetic analysis. For 
the parent N peptide, analyte concentrations of 500 µM and 1 
mM yielded a poor fit. Thus, individual curves used for the global 
analysis of N peptide-HSP72 interaction were generated by 
peptide concentrations of 25 µM, 50 µM, 100 µM, and 200 µM. 
The equilibrium dissociation constant thus derived was 1 µM, a 
calculated KD within the range reported for peptides mimicking 
the HSP72-interactive domain of p53 (i.e., <200 µM) and 
consistent with affinity values reported for well-characterized 
HSP72-mediated activity control reactions (6, 20, 29). Deviation 
of sensorgrams from the Langmuir model at high analyte 
concentrations may be explained by the degree to which the KD 
is exceeded. Given the fact that an analyte concentration equal to 
the equilibrium constant will give 50% saturation of the surface, 
excessive analyte concentrations can completely saturate binding 
sites, promoting second-site interactions and confounding kinetic 
analyses. Mutant peptides included an N to D with/without an 
additional L to P substitution, a design based upon naturally 
occurring polymorphisms of MV strains. Nucleocapsid protein 
sequence analysis of 17 measles central nervous system isolates 
demonstrate that 77% harbor either N to D (4D) or both L to P 
and N to D (3P4D) substitutions at the carboxyl terminus. A 
DnaK binding preference for L and negative bias for acidic 
residues is reported (18). It was therefore predicted that these 
amino acid substitutions would reduce HSP72 binding affinity. 
For mutant peptide, binding at 25 and 50 µM could either not be 
demonstrated or resultant sensorgrams gave a poor fit to the 
Langmuir binding model. Curves derived from 100 µM, 200 µM, 
500 µM, and 1 mM of mutant peptide concentrations exhibited 
good individual fits to the Langmuir model and were therefore 
subjected to global analysis. KD values of substituted peptide-
HSP72 interactions were 782 µM for 4D and 329 µM for 3P4D 
peptides, respectively (Table 1). The binding analysis showed that 
the basis for reduced binding affinity for these peptides was a 20 
to 50-fold slower association rate than peptide representing wild 
type N sequence and dissociation rates that were approximately 
10 times faster. 
 
Repeated analysis of peptide-HSP72 binding affinities showed 
minimal between-trial variation that was associated with 
reductions in HSP72 binding capacity with time and/or repeated 
use. For example, the same surface that generated a maximal 
response  of 250 RU for peptide binding during one trial 
generated a response of 210 RU after 4 days of storage, 
representing a 16% decrease in HSP72 activity. Loss in binding 
capacity was not attributed to dissociation of ligand from the 
sensor surface since the baseline sensorgam values were relatively 
constant. The impact upon calculated binding affinity was 
minimal, increasing the KD  describing N peptide-HSP72 
interactions to only 4 µM, a value that remains within the range 
of activity control reactions. An absolute value describing N 
peptide-HSP72 interaction is thus best represented by combining 
results of multiple experimental trials using freshly prepared 
sensor surfaces. Recognition of the limited life span of HSP72 
function influenced experimental design. Analysis of mutant 
peptides were performed in sequence with parent peptide during 
the same experimental trial, where parent N peptide analysis both 
preceded and followed analysis of mutant peptide in order to 
establish the degree of variation in HSP72 binding activity. 
Reductions in binding capacity were negligible (i.e., < 1%) when 
3 analytes at 5 concentrations per peptide were examined. When 
between trial variations in HSP72 binding capacity were 
observed, relative differences in HSP72 binding affinity for the 
various peptides were maintained.  
 
Kinetic measurements using RNP 
 
Peptides based upon carboxyl terminal sequences of the N 
protein lack the context of the biological system, where upstream 
N protein domains and domains of neighboring N proteins in the 
RNP structure may influence HSP72 binding reactions. Binding 
of the N protein carboxyl terminus to HSP72 was thus analyzed 
in the context of RNP particles, comparing binding rates and 
affinities to those calculated using N peptides. The contribution Zhang and Oglesbee     
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of the N protein carboxyl terminus to RNP-HSP72 binding 
reactions was established using RNP composed of intact N 
protein or N protein in which the carboxyl terminal 15 kDa was 
removed by selective proteolysis. Viral RNP was purified from 
the cytoplasm of infected Vero cells and a portion of the isolate 
subjected to treatment with Staphlococcal V8 protease. The degree 
to which the N protein was truncated as a result of this digestion 
was confirmed by Western blot analysis using MV N protein 
specific monoclonal antibody recognizing the amino terminus. 
The RNP helix is preserved following removal of the carboxyl 
terminal fragment (26), allowing direct comparison of binding 
reactions between parent RNP and RNP composed of truncated 
N proteins. For RNP-HSP72 binding affinity analysis, only 250 
RU HSP72 was immobilized. The low immobilization was used 
so that the theoretic maximal RNP binding response would fall 
below 250 RU. The calculation was based on Rmax = 
(MWA/MWL) x RL x Sm where in this case analyte and ligand have 
a similar molecular weight. RNP N protein concentrations of 5, 
10, 20, 40, and 80 nM were used for a global analysis of binding 
reactions, again using the 1:1 Langmuir binding model. Intact 
RNP bound HSP72 with a KD equal to 16 nM whereas cleavage 
of the N protein C-terminus decreased RNP binding affinity for 
HSP72 by 27-fold (KD = 428 nM), supporting the role of the 
carboxyl terminus of MV N protein in mediating RNP 
interactions with HSP72 (Table 2). The higher binding affinity of 
intact MV RNP relative to N peptide for HSP72 may be 
attributed to the multiple N monomers present within a given 
RNP fragment, all of which would participate in solid-phase 
HSP72 binding. Consistent with this view, the increased HSP72 
binding affinity of RNP relative to peptide was due 
predominantly with a slower off rate, a characteristic of 
multivalent binding relative to monovalent interactions. It is 
unlikely that other protein components of the RNP preparations 
(i.e., P and L proteins) make significant contributions to HSP72 
binding given the molar excess of N relative to P and L in the 
RNP preparations, particularly the high N:L ratio. In addition, 
extensive colocalization of HSP72 and N within morbillivirus 
infected cells is contrasted to an absence of colocalization 
between HSP72 and P (14). The molar excess of N and selective 
colocalization of N and HSP72 support the conclusion that N 
protein is the predominant contributor to RNP-HSP72 binding 
reactions. 
 
An alternate explanation for the relatively high affinity for RNP 
and HSP72 is that additional HSP72 binding sites are present on 
the N protein carboxyl terminus. Additional sites of relatively 
high binding affinity would explain the ability to isolate stable 
complexes between HSP72 and viral RNP by CsCl isopycnic 
density centrifugation (11, 12, 23). Although the isolation 
procedure is adequate for the retention of viral P and L proteins 
on the RNP template, it is improbable that HSP72 would remain 
bound to a target sequence when the KD for that reaction is in 
the 1-4 µM range. Recent unpublished data from our laboratory 
support this view. Rescue of recombinant infectious virus 
containing either the parent Ed-MV HSP72 binding motif or the 
4D-substituted motif allowed the analysis of RNP composition in 
cellular environments characterized by elevated HSP72 levels. 
RNP recovered from both viral variants exhibited stable complex 
formation with HSP72 despite loss of functional HSP72 
responsiveness by the 4D variant. These results support the 
presence of additional HSP72 binding sites on the viral RNP, 
although these sites are not relevant to functional interactions 
mediated by the HSP72 binding motif at amino acid position 
518-524 of the N protein. Sequence analysis of the N protein 
carboxyl terminus reveals a second putative target sequence at 
amino acids 495-501 (LLRLQAM), where high affinity for 
HSP72 is predicted. Work in progress will use BIAcore analysis 
to define the role of this motif in mediating RNP-HSP72 
interactions.   
 
Results of the peptide binding studies suggest that parent N 
sequences should interact functionally with HSP72 whereas 
mutant sequences should not. The KD’s  from these analyses 
model monovalent interactions that would occur between RNP 
N protein constituents and HSP72 in solution (i.e., HSP72 in the 
soluble cell fraction). The intracellular concentration of HSP72 in 
the soluble cell fraction that promotes functional interactions 
between HSP72 and viral RNP was previously estimated to be 
0.1 µM (11). Since the KD describing N-HSP72 binding reactions 
is 1.0 µM, significant RNP-HSP72 interaction would be predicted 
within the cell, although saturation of N protein binding sites 
would be below 50%.  
 
The relationship between target sequence variation in HSP72 
binding affinity and functional interactions with HSP72 was 
addressed in our published work using a reverse genetics system 
to measure HSP72-dependent changes in MV transcription and 
genomic replication (15). In this system, a MV transcriptional 
complex is reconstituted by transiently transfecting cells with 
plasmid constructs expressing N ,  P ,  L ,  a n d  a  M V  g e n o m e  
containing the CAT reporter gene. Addition of HSP72 by 
transfection stimulates viral transcriptional activity by 2-3 fold for 
wild type MV N as measured by CAT reporter gene expression. 
N proteins containing the C-terminal 4D and 3P4D substitutions 
lack a response to HSP72 supplementation. The significant loss 
in binding affinity between N protein sequences and HSP72 
documented with the BIAcore system were thus correlated to 
loss of functional interactions using the reverse genetics 
approach.  
 
BIAcore analysis will also be of value in identifying functionally 
homologous domains in related paramyxoviruses. The 
Onderstepoort strain of CDV has an N protein carboxyl terminal 
sequence (i.e., YSDKELL) homologous to that of the MV 4D 
variant since it contains a second acid side group (E) in the 
binding motif yet it retains HSP72 responsiveness in assays of 
viral transcription and genome replication (Oglesbee et al., 
unpublished observation). An explanation for the retention in 
HSP72 responsiveness can be found when the composition of 
the complete carboxyl terminal sequence is examined. The 
terminal amino acid for MV is D (i.e., YNDRNLLD) while that 
of CDV is N (i.e., YSDKELLN), making the total content of 
acidic side groups in the terminal 8 amino acids comparable. 
Preliminary studies in our laboratory have shown that N peptides 
representing the carboxyl terminal 15 amino acids of CDV and 
MV bind with comparable affinity, supporting the idea that Zhang and Oglesbee     
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binding is defined by a greater degree of primary sequence than 
was originally envisioned. BIAcore analysis will be ideally suited 
to more completely map the extent of sequences influencing 
functional HSP72-viral interactions, and the nature of 
functionally homologous motifs in other viral species. 
 
Collectively, use of soluble peptide analytes and immobilized 
HSP72 in the BIAcore system allowed us to model solution 
interactions between HSP72 and viral RNP. The approach 
overcame numerous technical obstacles imposed by the 
insolubility of one of the binding partners (i.e., N protein) and 
the unwieldy form of the macromolecular complex formed by 
the N protein, namely the filamentous RNP helix. The result was 
that we were able to identify structural determinants of functional 
interactions between HSP72 and viral RNP. These results 
highlight the power of surface plasmon resonance technology in 
guiding molecular studies of virus-host interaction. Applications 
extend far beyond analysis of protein-protein and protein-peptide 
binding and include protein-DNA, protein-cell, and virus-cell 
interactions, making likely the increased use of this technology in 
the virology research laboratory. 
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FIGURES AND TABLES 
 
 
Fig. 1:  BIAcore 3000 sensorgrams demonstrating a decline in HSP72 binding capacity as a function of chip storage. HSP72 was immobilized on a CM5 chip at 
20,000 RU, where 1,000 RU=1 ng/mm2 of HSP72 on the surface. Interaction between 200 µM N peptide and HSP72 was indicated by a change in RU over the course of 
the 300 s injection interval. The same sensor surface after 4 d of storage at 4°C gave rise to a maximal response that was 40 RU less than that generated in the previous 
trial when binding with freshly prepared peptide solution was examined, representing a 16% decrease in HSP72 binding capacity. The loss in binding capacity did not 
reflect loss of HSP72 from the sensor surface, based upon lack of change in the baseline sensorgram readings. 
 
 
Fig. 2: ATP accelerates peptide dissociation from HSP72. A 400 µM N peptide solution was passed over a surface containing 20,000 RU HSP72. Peptide 
dissociation was examined in HBS-P running buffer containing 2.5mM magnesium acetate and either high (0.1 mM) or low (2.5 mM) ATP concentrations. Following 
injection beginning at Tstart, progressive association between peptide and sensor was observed, reflecting the excess of HSP72 ligand and failure of either reaction to 
achieve binding equilibrium. At the end of injection (Tend), analyte dissociation was observed. The N peptide dissociation rate from HSP72 was 3 times faster in buffer 
solution containing 2.5 mM ATP compared to 0.1 mM ATP. The higher ATP concentration did diminish the magnitude of maximal peptide response, consistent with the 
role of ATP in promoting HSP72-substrate dissociation. Zhang and Oglesbee     
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Fig. 3: Mg++ selectively enhances peptide binding for HSP72 but not irrelevant ligand. (A) Four hundred µM N peptide was passed over sensors containing 
either 20,000 RU HSP72 or an irrelevant ligand (IgG) to which peptide binding was not predicted. Reaction buffer lacked Mg++. At the end of injection, the magnitude of 
the N Peptide-HSP72 binding response was 40 RU higher than the maximal peptide-IgG interaction. The IgG and HSP72 immobilization levels were comparable 
although not identical, differing by a factor of 3. (B) Binding in HBS buffer with 2.5 mM magnesium acetate and 400 µM N peptide showed no change in the peptide-
IgG interaction whereas peptide-HSP72 binding was greatly enhanced, yielding a response 250 RU above the peptide-IgG interaction. 
 
 
Fig. 4: N peptide competitive inhibition of MV RNP-HSP72 interaction. MV RNP representing 1 nM N protein was passed over HSP72 in the presence or absence 
of N peptide. N peptide concentrations of 5, 20, and 50µM decreased the magnitude of RNP binding to immobilized HSP72 in a peptide dosage-dependent manner. The 
same competitive inhibition experiment was performed using the negative-control MBP peptide. The level of inhibition achieved with 400 µM MBP peptide was 
comparable to that using only 5 µM N peptide. Zhang and Oglesbee     
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Fig. 5: Quality of fit between sensorgrams and the 1:1 Langmuir binding model, when a range of N peptide concentrations interacting with either 10,000 
RU or 20,000 RU of immobilized HSP72 was examined. (A) Top panel illustrates dosage-dependent binding of N peptide to 10,000 RU of immobilized HSP72. 
Binding was corrected for nonspecific interactions with the sensor. Peptide concentrations of 25, 50, 100, and 200 µM allowed high-quality global fitting to the 1:1 
binding model with drifting baseline. The quality of fitting was demonstrated by the residual plot (bottom panel, A) where the difference between the experimental and 
reference data was randomly distributed about the X-axis within the ± 2.0 range. Quality of fit became less at higher analyte concentrations (i.e., 200 µM), where residuals 
distribute in a more curvilinear manner and become greater in magnitude. The KD thus derived was 1 µM. (B) N peptide binding to 20,000 RU HSP72 was not suited to 
kinetic analysis due to deviation from the 1:1 binding model. Sensorgrams for the interaction between HSP72 and N peptide concentrations of 25, 50, 100, and 200 µM 
yielded residuals that exceeded the ± 2 range and were consistently curvilinear (i.e., non-randomly distributed along the X-axis), regardless of peptide concentration. 
 
Table 1: Sensorgrams for the interaction between HSP72 and N peptide concentrations of 25, 50, 100, and 200 µM allowed high-quality global fitting to a 1:1 Langmuir 
binding model. Calculated equilibrium dissociation constants (KD), on rate (ka), and off rate (kd) are shown. High-quality global fitting for N4D and N3P4D peptide was 
based upon sensorgrams generated with 100, 200, 500, and 1000 µM peptide concentrations. The HSP72 immobilization level was 10,000 RU. 
Quality of Fit  Peptide Analyte 
Residuals Chi2 
ka 
(1/Ms) 
kd 
(1/s) 
KD 
(µM) 
N  -1.8 – 1.8  0.23  357  4.1 x 10-4  1 
N4D  -1.0 – 1.6  0.09  7  5.5 x 10-3  782 
N3P4D  -1.0 – 2.1  0.22  14  4.4 x 10-3  329 
 
Table 2: Sensorgrams for the interaction between HSP72 and RNP N protein concentrations of 5, 10, 20, 40, and 80 nM allowed high-quality global fitting to a 1:1 
Langmuir binding model, allowing the computation of KD and association and dissociation rate constants ka and kd. This binding reaction was compared to that of RNP 
subject to selective proteolysis with Staphylococcus aureus V8 protease. 
Quality of Fit  Analyte 
Residuals Chi2 
ka 
(1/Ms) 
kd 
(1/s) 
KD 
(nM) 
RNP  -1.5 – 1.5  0.32  643  1 x 10-5 16 
RNP + V8  -1.0 – 1.0  0.22  23  1 x 10-5 428 
 